SK12798A3 - Imidazopyridine derivatives, method for producing thereof, pharmaceutical composition containing same and their use - Google Patents

Imidazopyridine derivatives, method for producing thereof, pharmaceutical composition containing same and their use Download PDF

Info

Publication number
SK12798A3
SK12798A3 SK127-98A SK12798A SK12798A3 SK 12798 A3 SK12798 A3 SK 12798A3 SK 12798 A SK12798 A SK 12798A SK 12798 A3 SK12798 A3 SK 12798A3
Authority
SK
Slovakia
Prior art keywords
pyridin
prop
enyl
tolyl
methylimidazo
Prior art date
Application number
SK127-98A
Other languages
English (en)
Slovak (sk)
Inventor
Andrew P Ayscough
Christopher M Blackwell
Steven Launchbury
Mark Whittaker
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9516115.4A external-priority patent/GB9516115D0/en
Priority claimed from GBGB9608592.3A external-priority patent/GB9608592D0/en
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of SK12798A3 publication Critical patent/SK12798A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK127-98A 1995-08-05 1996-07-30 Imidazopyridine derivatives, method for producing thereof, pharmaceutical composition containing same and their use SK12798A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9516115.4A GB9516115D0 (en) 1995-08-05 1995-08-05 Imidazopyridine derivates
GBGB9608592.3A GB9608592D0 (en) 1996-04-24 1996-04-24 Imidazopyridine derivatives
PCT/GB1996/001849 WO1997006167A1 (en) 1995-08-05 1996-07-30 Imidazopyridine derivatives

Publications (1)

Publication Number Publication Date
SK12798A3 true SK12798A3 (en) 1998-08-05

Family

ID=27267850

Family Applications (1)

Application Number Title Priority Date Filing Date
SK127-98A SK12798A3 (en) 1995-08-05 1996-07-30 Imidazopyridine derivatives, method for producing thereof, pharmaceutical composition containing same and their use

Country Status (10)

Country Link
US (1) US5866588A (pt)
EP (1) EP0842175A1 (pt)
JP (1) JPH11510180A (pt)
AU (1) AU698487B2 (pt)
BR (1) BR9609892A (pt)
GB (1) GB2308593B (pt)
MX (1) MX9707187A (pt)
NZ (1) NZ313726A (pt)
SK (1) SK12798A3 (pt)
WO (1) WO1997006167A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797820B2 (en) * 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
JP4591349B2 (ja) 2003-07-14 2010-12-01 宇部興産株式会社 ４−アミノテトラヒドロピラン化合物及びその酸塩の製法、その合成中間体およびその製法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44821B (en) * 1982-02-04 1991-02-28 Wellcome Found Process for obtaiing new pyridyl derivatives
US4621094A (en) * 1983-03-10 1986-11-04 Findlay John W A Anti-histaminic pyridyl compounds
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
GB9107398D0 (en) * 1991-04-09 1991-05-22 British Bio Technology Compounds

Also Published As

Publication number Publication date
GB9708363D0 (en) 1997-06-18
AU6625496A (en) 1997-03-05
US5866588A (en) 1999-02-02
AU698487B2 (en) 1998-10-29
MX9707187A (es) 1997-11-29
WO1997006167A1 (en) 1997-02-20
JPH11510180A (ja) 1999-09-07
NZ313726A (en) 1998-11-25
GB2308593B (en) 1999-01-27
BR9609892A (pt) 1999-05-25
GB2308593A (en) 1997-07-02
EP0842175A1 (en) 1998-05-20

Similar Documents

Publication Publication Date Title
JP4592077B2 (ja) 嘔吐、抑鬱、不安および咳の処置のためのニューロキニン−１（ｎｋ−１）アンタゴニストとしての１−アミド−４−フェニル−４−ベンジルオキシメチル−ピペリジン誘導体および関連化合物
JP5767631B2 (ja) バニロイド受容体リガンドとしての置換された芳香族カルボキサミドおよび尿素誘導体
TWI491595B (zh) 作為香草類化合物受體之配體之經取代苯基尿素及苯基醯胺
JP4054369B2 (ja) オルト置換アリールまたはヘテロアリールアミド化合物
CN103772239B (zh) 酰胺和脒衍生物和其用途
JP2008540597A (ja) 置換されたべンゾ［ｄ］イソオキサゾール−３−イル−アミン−化合物及バニロイド受容体リガンドとしてのその使用
JP2013545740A (ja) バニロイド受容体リガンドとしての置換された複素芳香族カルボキサミド誘導体および尿素誘導体
JP5617919B2 (ja) テトラヒドロベンゾチオフェン化合物
US8642775B2 (en) Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions
CN107108593B (zh) 作为类香草素受体配体ii的基于取代的恶唑和噻唑的羧酰胺和脲衍生物
MXPA06002551A (es) Compuestos de aril o heteroaril amida.
WO2007017092A1 (en) Substituted 4-benzyloxy-benzoic acid amide derivatives
DE19730989A1 (de) Piperazin-Derivate
JP2014521618A (ja) 置換複素環アザ誘導体
US6127343A (en) Somatostatin agonists and antagonists
JP2013534229A (ja) バニロイド受容体リガンドとしての置換された環状カルボキサミド誘導体および尿素誘導体
EP1539724A1 (en) Amino benzothiazole compounds with nos inhibitory activity
JP2014518281A (ja) 電位依存性ナトリウムチャネル遮断薬
JP2014521617A (ja) バニロイド受容体リガンドとしての置換二環性芳香族カルボキサミドおよび尿素誘導体
US5753671A (en) Imidazopyridine derivatives as dual histamine (H1) and platelet activating factor (PAF) antagonists
KR950014568B1 (ko) 융합된 이미다조헤테로사이클릭 화합물, 이의 제조방법 및 이를 함유하는 약제학적 조성물
SK12798A3 (en) Imidazopyridine derivatives, method for producing thereof, pharmaceutical composition containing same and their use
US6159941A (en) Use of somatostatin agonists and antagonists for treating diseases related to the eye
EP3130589A1 (en) Heterocyclic aza compounds
US8735426B2 (en) Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them and use thereof for treating pain and other conditions